RxSight (RXST) Other Non Operating Income (2022 - 2024)

RxSight (RXST) has reported Other Non Operating Income for 3 consecutive years, with -$3.6 million the latest figure, recorded in Q4 2024.

• For the quarter ending Q4 2024, Other Non Operating Income fell 9975.0% year-over-year to -$3.6 million; the trailing twelve-month figure through Dec 2024 stood at -$3.7 million (down 583.4% YoY), and the FY2025 full-year result was $272000.0, up 107.5% from the prior year.
• Other Non Operating Income slipped to -$3.6 million in Q4 2024 per RXST's latest filing, from -$36000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $1.3 million in Q4 2022 and bottomed at -$3.6 million in Q4 2024.
• Historically, Other Non Operating Income has averaged -$832600.0 across 3 years, with a median of -$362000.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Other Non Operating Income tumbled 102.84% in 2023, then slumped 9975.0% in 2024.
• Over 3 years, Other Non Operating Income stood at $1.3 million in 2022, then sank by 102.84% to -$36000.0 in 2023, then plunged by 9975.0% to -$3.6 million in 2024.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$3.6 million, -$36000.0, and -$1.4 million for Q4 2024, Q4 2023, and Q3 2023 respectively.